NovoCure Limited
DE ˙ DB ˙ JE00BYSS4X48
€ 13,66 ↑0.85 (6.63%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:038 / NovoCure Limited
InstitutionUBS Group AG
Latest Disclosed Ownership245,817 shares
Latest Disclosed Value $ 2,679,406
UBS Group AG ownership in 038 / NovoCure Limited

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 245,817 shares of NovoCure Limited (DE:038) valued at $2,165,648 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 148,519 shares of NovoCure Limited. This represents a change in shares of 65.51% during the quarter. The current value of the position is $3,359,089 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (038) in the form of stock options. The firm currently holds call options representing 44,000 of underlying shares valued at $479,600 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:038 / NovoCure Limited Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F NOVOCURE ORD SHS G6674U108 245,817 97,298 65.51 2,679 39.53 0.0001
2026-01-29 2025-12-31 13F NOVOCURE ORD SHS G6674U108 148,519 66,544 81.18 1,920 81.30 0.0003
2025-11-13 2025-09-30 13F NOVOCURE ORD SHS G6674U108 81,975 -191,407 -70.01 1,059 -78.24 0.0002
2025-08-14 2025-06-30 13F NOVOCURE ORD SHS G6674U108 273,382 -130,157 -32.25 4,866 -32.33 0.0008
2025-05-13 2025-03-31 13F NOVOCURE ORD SHS G6674U108 403,539 -120,570 -23.00 7,191 -53.96 0.0013
2025-02-14 2024-12-31 13F NOVOCURE ORD SHS G6674U108 524,109 369,139 238.20 15,618 544.84 0.0029
2024-11-14 2024-09-30 13F NOVOCURE ORD SHS G6674U108 154,970 -255,748 -62.27 2,422 -65.57 0.0005
2024-08-14 2024-06-30 13F NOVOCURE ORD SHS G6674U108 410,718 65,054 18.82 7,036 30.23 0.0017
2024-05-13 2024-03-31 13F NOVOCURE ORD SHS G6674U108 345,664 328,760 1,944.87 5,403 2,043.65 0.0013
2024-02-09 2023-12-31 13F NOVOCURE ORD SHS G6674U108 16,904 12,193 258.82 252 231.58 0.0001
2023-11-09 2023-09-30 13F NOVOCURE ORD SHS G6674U108 4,711 -5,958 -55.84 76 -82.81 0.0000
2023-08-11 2023-06-30 13F NOVOCURE ORD SHS G6674U108 10,669 -3,655 -25.52 443 -48.66 0.0001
2023-05-12 2023-03-31 13F NOVOCURE ORD SHS G6674U108 14,324 -201 -1.38 861 -19.15 0.0003
2023-02-08 2022-12-31 13F NOVOCURE ORD SHS G6674U108 14,525 4,622 46.67 1,065 41.43 0.0004
2022-11-10 2022-09-30 13F NOVOCURE ORD SHS G6674U108 9,903 2,968 42.80 753 56.22 0.0003
2022-08-10 2022-06-30 13F NOVOCURE ORD SHS G6674U108 6,935 -1,945 -21.90 482 -34.51 0.0002
2022-05-16 2022-03-31 13F NOVOCURE ORD SHS G6674U108 8,880 -2,756 -23.69 736 -15.79 0.0002
2022-02-14 2021-12-31 13F NOVOCURE ORD SHS G6674U108 11,636 1,969 20.37 874 -22.17 0.0003
2021-11-15 2021-09-30 13F NOVOCURE ORD SHS G6674U108 9,667 -3,531 -26.75 1,123 -61.63 0.0004
2021-08-13 2021-06-30 13F NOVOCURE ORD SHS G6674U108 13,198 -42,185 -76.17 2,927 -60.02 0.0009
2021-05-12 2021-03-31 13F NOVOCURE ORD SHS G6674U108 55,383 1,514 2.81 7,321 -21.47 0.0024
2021-02-11 2020-12-31 13F NOVOCURE ORD SHS G6674U108 53,869 26,007 93.34 9,322 200.52 0.0032
2020-11-12 2020-09-30 13F NOVOCURE ORD SHS G6674U108 27,862 19,681 240.57 3,102 539.59 0.0012
2020-07-31 2020-06-30 13F NOVOCURE ORD SHS G6674U108 8,181 -55,435 -87.14 485 -88.68 0.0002
2020-05-01 2020-03-31 13F NOVOCURE ORD SHS G6674U108 63,616 -78,602 -55.27 4,284 -64.25 0.0020
2020-02-14 2019-12-31 13F NOVOCURE ORD SHS G6674U108 142,218 62,517 78.44 11,984 101.07 0.0042
2019-11-14 2019-09-30 13F NOVOCURE ORD SHS G6674U108 79,701 40,953 105.69 5,960 143.27 0.0023
2019-08-14 2019-06-30 13F NOVOCURE ORD SHS G6674U108 38,748 38,045 5,411.81 2,450 7,105.88 0.0009
2019-05-14 2019-03-31 13F NOVOCURE ORD SHS G6674U108 703 -1,324 -65.32 34 -50.00 0.0000
2019-02-14 2018-12-31 13F NOVOCURE ORD SHS G6674U108 2,027 -19,013 -90.37 68 -93.83 0.0000
2018-11-14 2018-09-30 13F NOVOCURE ORD SHS G6674U108 21,040 -6,195 -22.75 1,103 29.31 0.0004
2018-08-14 2018-06-30 13F NOVOCURE ORD SHS G6674U108 27,235 17,426 177.65 853 298.60 0.0004
2018-05-15 2018-03-31 13F NOVOCURE ORD SHS G6674U108 9,809 7,762 379.19 214 421.95 0.0001
2018-02-14 2017-12-31 13F NOVOCURE ORD SHS G6674U108 2,047 -6,071 -74.78 41 -74.53 0.0000
2017-11-14 2017-09-30 13F NOVOCURE ORD SHS G6674U108 8,118 -498 -5.78 161 8.05 0.0001
2017-11-14 2017-06-30 13F/A-1 NOVOCURE ORD SHS G6674U108 8,616 4,630 116.16 149 365.63 0.0001
2017-08-14 2017-06-30 13F NOVOCURE ORD SHS G6674U108 8,616 4,630 149
2017-11-14 2017-03-31 13F/A-1 NOVOCURE ORD SHS G6674U108 3,986 -3,745 -48.44 32 -47.54 0.0000
2017-05-12 2017-03-31 13F NOVOCURE ORD SHS G6674U108 3,986 -3,745 32
2017-02-14 2016-12-31 13F NOVOCURE ORD SHS G6674U108 7,731 1,171 17.85 61 8.93 0.0000
2016-11-14 2016-09-30 13F NOVOCURE ORD SHS G6674U108 6,560 -2,441 -27.12 56 -46.67 0.0000
2016-08-12 2016-06-30 13F NOVOCURE ORD SHS G6674U108 9,001 7,514 505.31 105 377.27 0.0001
2016-05-12 2016-03-31 13F NOVOCURE ORD SHS G6674U108 1,487 -10,727 -87.83 22 -91.94 0.0000
2016-02-16 2015-12-31 13F NOVOCURE ORD SHS G6674U108 12,214 12,214 273 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F NOVOCURE ORD SHS Call 44,000 480 n/a n/a n/a
2025-08-14 2025-06-30 13F NOVOCURE ORD SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-13 2025-03-31 13F NOVOCURE ORD SHS Call 203,500 -11.41 3,626 -47.03 n/a n/a n/a
2025-02-14 2024-12-31 13F NOVOCURE ORD SHS Call 229,700 14.85 6,845 118.97 n/a n/a n/a
2024-11-14 2024-09-30 13F NOVOCURE ORD SHS Call 200,000 -25.27 3,126 -31.81 n/a n/a n/a
2024-08-14 2024-06-30 13F NOVOCURE ORD SHS Call 267,627 4,584 n/a n/a n/a
2024-05-13 2024-03-31 13F NOVOCURE ORD SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-09 2023-12-31 13F NOVOCURE ORD SHS Call 38,600 -6.99 576 -14.03 n/a n/a n/a
2023-11-09 2023-09-30 13F NOVOCURE ORD SHS Call 41,500 0.00 670 -61.09 n/a n/a n/a
2023-08-11 2023-06-30 13F NOVOCURE ORD SHS Call 41,500 -38.24 1,722 -57.39 n/a n/a n/a
2023-05-12 2023-03-31 13F NOVOCURE ORD SHS Call 67,200 66.75 4,041 36.71 n/a n/a n/a
2023-02-08 2022-12-31 13F NOVOCURE ORD SHS Call 40,300 444.59 2,956 425.98 n/a n/a n/a
2022-11-10 2022-09-30 13F NOVOCURE ORD SHS Call 7,400 0.00 562 9.34 n/a n/a n/a
2022-08-10 2022-06-30 13F NOVOCURE ORD SHS Call 7,400 0.00 514 -16.15 n/a n/a n/a
2022-05-16 2022-03-31 13F NOVOCURE ORD SHS Call 7,400 0.00 613 10.25 n/a n/a n/a
2022-02-14 2021-12-31 13F NOVOCURE ORD SHS Call 7,400 0.00 556 -35.35 n/a n/a n/a
2021-11-15 2021-09-30 13F NOVOCURE ORD SHS Call 7,400 -70.40 860 -84.49 n/a n/a n/a
2021-08-13 2021-06-30 13F NOVOCURE ORD SHS Call 25,000 5,546 n/a n/a n/a
2020-02-14 2019-12-31 13F NOVOCURE ORD SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F NOVOCURE ORD SHS Call 18,600 -62.80 1,391 -56.01 n/a n/a n/a
2019-08-14 2019-06-30 13F NOVOCURE ORD SHS Call 50,000 0.00 3,162 31.26 n/a n/a n/a
2019-05-14 2019-03-31 13F NOVOCURE ORD SHS Call 50,000 0.00 2,409 -23.81 n/a n/a n/a
2019-02-14 2018-12-31 13F NOVOCURE ORD SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F NOVOCURE ORD SHS Call 50,000 0.00 2,620 67.41 n/a n/a n/a
2018-08-14 2018-06-30 13F NOVOCURE ORD SHS Call 50,000 0.00 1,565 -40.27 n/a n/a n/a
2018-02-14 2017-12-31 13F NOVOCURE ORD SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F NOVOCURE ORD SHS Call 75,000 0.00 1,489 14.71 n/a n/a n/a
2017-11-14 2017-06-30 13F/A NOVOCURE ORD SHS Call 75,000 0.00 1,298 113.49 n/a n/a n/a
2017-08-14 2017-06-30 13F NOVOCURE ORD SHS Call 75,000 1,298 n/a n/a n/a
2017-11-14 2017-03-31 13F/A NOVOCURE ORD SHS Call 75,000 608 n/a n/a n/a
2017-05-12 2017-03-31 13F NOVOCURE ORD SHS Call 75,000 608 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-13 2025-03-31 13F NOVOCURE ORD SHS Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F NOVOCURE ORD SHS Put 200 0.00 6 66.67 n/a n/a n/a
2024-11-14 2024-09-30 13F NOVOCURE ORD SHS Put 200 0.00 3 0.00 n/a n/a n/a
2024-08-14 2024-06-30 13F NOVOCURE ORD SHS Put 200 -98.18 3 -98.25 n/a n/a n/a
2024-05-13 2024-03-31 13F NOVOCURE ORD SHS Put 11,000 -92.36 172 -92.04 n/a n/a n/a
2024-02-09 2023-12-31 13F NOVOCURE ORD SHS Put 143,900 0.00 2,148 -7.53 n/a n/a n/a
2023-11-09 2023-09-30 13F NOVOCURE ORD SHS Put 143,900 66.94 2,324 -35.06 n/a n/a n/a
2023-08-11 2023-06-30 13F NOVOCURE ORD SHS Put 86,200 797.92 3,577 519.93 n/a n/a n/a
2023-05-12 2023-03-31 13F NOVOCURE ORD SHS Put 9,600 4.35 577 -14.39 n/a n/a n/a
2023-02-08 2022-12-31 13F NOVOCURE ORD SHS Put 9,200 0.00 675 -3.58 n/a n/a n/a
2022-11-10 2022-09-30 13F NOVOCURE ORD SHS Put 9,200 0.00 699 9.39 n/a n/a n/a
2022-08-10 2022-06-30 13F NOVOCURE ORD SHS Put 9,200 0.00 639 -16.14 n/a n/a n/a
2022-05-16 2022-03-31 13F NOVOCURE ORD SHS Put 9,200 0.00 762 10.27 n/a n/a n/a
2022-02-14 2021-12-31 13F NOVOCURE ORD SHS Put 9,200 0.00 691 -35.36 n/a n/a n/a
2021-11-15 2021-09-30 13F NOVOCURE ORD SHS Put 9,200 -81.60 1,069 -90.36 n/a n/a n/a
2021-08-13 2021-06-30 13F NOVOCURE ORD SHS Put 50,000 11,091 n/a n/a n/a
2021-05-12 2021-03-31 13F NOVOCURE ORD SHS Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F NOVOCURE ORD SHS Put 16,600 18.57 2,872 84.34 n/a n/a n/a
2020-11-12 2020-09-30 13F NOVOCURE ORD SHS Put 14,000 0.00 1,558 87.71 n/a n/a n/a
2020-07-31 2020-06-30 13F NOVOCURE ORD SHS Put 14,000 0.00 830 -11.98 n/a n/a n/a
2020-05-01 2020-03-31 13F NOVOCURE ORD SHS Put 14,000 -46.36 943 -57.12 n/a n/a n/a
2020-02-14 2019-12-31 13F NOVOCURE ORD SHS Put 26,100 115.70 2,199 142.98 n/a n/a n/a
2019-11-14 2019-09-30 13F NOVOCURE ORD SHS Put 12,100 905 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.